Biggest News Aggregation in the World
📰 Final Draft News

Page 12 - Final Draft News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Final Draft. Real-time updates on events, politics, business and more.

NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia

High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the National Institute for Health and Care Excellence (NICE) has recommended Imbruvica® (ibrutinib) plus venetoclax as an option for untreated chronic lymphocytic leukaemia (CLL) in adult...
High Wycombe United Kingdom Great Britain Ibrutinib Imbruvica Amanda Cunnington Hilary Lindsay

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science